Patients

CRISPR-Cas9 Delivered Directly to Human Sperm

The CRISPR genome editing method has been delivered directly in human sperm cells giving hope that correcting mutations in human sperm cells is possible and may lead to the prevention of disease being passed on by fathers.

Shifting the Patient Paradigm

The Greenwood Genetic Center (GGC) has embarked on a novel program to leverage traditional and emerging genomic technologies, in the search for answers for undiagnosed patients.